The Role of Direct-to-Consumer Pharmaceutical Advertising in Patient Consumerism
Bibliographic Data
| ID | 15746487 |
|---|---|
| Authors | Wang Bo (0000-0002-1494-1333, Harvard University, corresponding author), Aaron S Kesselheim (0000-0002-8867-2666) |
| Year | 2013 |
| Volume | 15 |
| Issue | 11 |
| Pages | 960-965 |
| Publication date | 2013-11-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/virtualmentor.2013.15.11.pfor1-1311 |
| PMID | 24257088 |
| OpenAlex | W1542363345 |
| Language | EN |
| Citations received | 1 |
| References cited | 1 |
In 2012, pharmaceutical and medical device manufacturers spent more than $4 billion in the U.S. to promote their products to patients These direct-to-consumer advertisements (DTCA) are disseminated via television and radio, magazines and newspapers, and-increasingly-the Internet. DTCA has important implications for the consumerism movement in health care. High-tech media like smartphones and the growth in wireless Internet connectivity are allowing more patients to access promotional information about potentially beneficial treatments, but the lack of firm regulatory guidelines governing DTCA may lead to suboptimal treatment decisions and health and economic outcomes
Advertising · Business · Consumerism · Direct-to-consumer advertising · Political science · Health Systems, Economic Evaluations, Quality of Life · Law · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Marketing · Pharmacology
| Unique citing works | 1 |
|---|---|
| Citations per year | 0.2 |
| Citation span | 2021 - 2021 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |